Variant report
Variant | nsv963050 |
---|---|
Chromosome Location | chr19:41383957-41386230 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr19:41383928-41383999 | LNCaP | prostate: | n/a | n/a |
2 | CTCF | chr19:41386211-41386665 | K562 | blood: | n/a | n/a |
3 | POLR2A | chr19:41386159-41386584 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | POLR2A | chr19:41386101-41386269 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | ZNF263 | chr19:41384603-41384719 | HEK293-T-REx | kidney: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:41385865-41385915 | GM12891 | blood: | n/a |
2 | chr19:41385865-41385915 | GM06990 | blood: | n/a |
3 | chr19:41385865-41385915 | GM12878 | blood: | n/a |
4 | chr19:41385865-41385915 | Hela-S3 | cervix: | n/a |
5 | chr19:41385865-41385915 | HIPEpiC | eye: | n/a |
6 | chr19:41385865-41385915 | SK-N-SH_RA | brain: | n/a |
7 | chr19:41385865-41385915 | Jurkat | blood: | n/a |
8 | chr19:41385865-41385915 | T-47D | breast: | n/a |
9 | chr19:41385865-41385915 | SK-N-MC | brain: | n/a |
10 | chr19:41385865-41385915 | BJ | skin: | n/a |
11 | chr19:41385865-41385915 | Hepatocyte | liver: | n/a |
12 | chr19:41385865-41385915 | HEEpiC | esophagus: | n/a |
13 | chr19:41385865-41385915 | HepG2 | liver: | n/a |
14 | chr19:41385865-41385915 | NB4 | blood: | n/a |
15 | chr19:41385865-41385915 | HUVEC | blood vessel: | n/a |
16 | chr19:41385865-41385915 | ECC-1 | luminal epithelium: | n/a |
17 | chr19:41385865-41385915 | MCF10A-Er-Src | breast: | n/a |
18 | chr19:41385865-41385915 | K562 | blood: | n/a |
19 | chr19:41385865-41385915 | HRE | kidney: | n/a |
20 | chr19:41385865-41385915 | HL-60 | blood: | n/a |
21 | chr19:41385865-41385915 | HAEpiC | amniotic membrane: | n/a |
22 | chr19:41385865-41385915 | HNPCEpiC | eye: | n/a |
23 | chr19:41385865-41385915 | HCM | heart: | n/a |
24 | chr19:41385865-41385915 | HEK293 | kidney: | embryo |
25 | chr19:41385865-41385915 | HCT-116 | colon: | n/a |
26 | chr19:41385865-41385915 | BE2_C | brain: | n/a |
27 | chr19:41385865-41385915 | HMEC | breast: | n/a |
28 | chr19:41385865-41385915 | U87 | brain: | n/a |
29 | chr19:41385865-41385915 | PFSK-1 | brain: | n/a |
30 | chr19:41385865-41385915 | MCF-7 | breast: | n/a |
31 | chr19:41385865-41385915 | IMR90 | lung: | fetal |
32 | chr19:41385865-41385915 | AG04449 | skin: | fetal |
33 | chr19:41385865-41385915 | LNCaP | prostate: | n/a |
34 | chr19:41385865-41385915 | HPAEpiC | pulmonary alveolar: | n/a |
35 | chr19:41385865-41385915 | RPTEC | kidney: | n/a |
36 | chr19:41385865-41385915 | AoSMC | blood vessel: | n/a |
37 | chr19:41385865-41385915 | NH-A | brain: | n/a |
38 | chr19:41385865-41385915 | Caco-2 | colon: | n/a |
39 | chr19:41385865-41385915 | SK-N-SH | brain: | n/a |
40 | chr19:41385865-41385915 | GM19239 | blood: | n/a |
41 | chr19:41385865-41385915 | HRPEpiC | eye: | n/a |
42 | chr19:41385865-41385915 | SKMC | muscle: | n/a |
43 | chr19:41385865-41385915 | PANC-1 | pancreas: | n/a |
44 | chr19:41385865-41385915 | ProgFib | skin: | n/a |
45 | chr19:41385865-41385915 | AG04450 | lung: | fetal |
46 | chr19:41385865-41385915 | NT2-D1 | testis: | n/a |
47 | chr19:41385865-41385915 | HCF | heart: | n/a |
48 | chr19:41385865-41385915 | GM12892 | blood: | n/a |
49 | chr19:41385865-41385915 | AG09319 | gingival: | n/a |
50 | chr19:41385865-41385915 | SAEC | small airway: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CYP2A7 | TF binding region |
CYP2A7 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558045870 | chr19:41383961-41383962 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs555155044 | chr19:41383978-41383979 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs3822479 | chr19:41383989-41383990 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs186325911 | chr19:41384031-41384032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs4079370 | chr19:41384067-41384068 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs2909906 | chr19:41384084-41384085 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs541031932 | chr19:41384092-41384093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559704244 | chr19:41384101-41384102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2935235 | chr19:41384102-41384103 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs548271843 | chr19:41384136-41384137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188541088 | chr19:41384153-41384154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs3882550 | chr19:41384158-41384159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552379064 | chr19:41384187-41384188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs3956338 | chr19:41384189-41384190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572902851 | chr19:41384196-41384197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570628709 | chr19:41384198-41384199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534934841 | chr19:41384255-41384256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181006947 | chr19:41384257-41384258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568066404 | chr19:41384258-41384259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368300400 | chr19:41384268-41384269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113090985 | chr19:41384281-41384282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535491255 | chr19:41384302-41384303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs142926681 | chr19:41384334-41384335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs147261284 | chr19:41384346-41384347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537219263 | chr19:41384347-41384348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559122628 | chr19:41384379-41384380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs71334950 | chr19:41384385-41384386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10402703 | chr19:41384386-41384387 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs559838920 | chr19:41384388-41384389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs532269726 | chr19:41384393-41384394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574480714 | chr19:41384394-41384395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113971769 | chr19:41384431-41384432 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185022523 | chr19:41384433-41384434 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530935643 | chr19:41384478-41384479 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552054838 | chr19:41384482-41384483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550188456 | chr19:41384491-41384492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528328004 | chr19:41384492-41384493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546871198 | chr19:41384521-41384522 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113986398 | chr19:41384533-41384534 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535417801 | chr19:41384542-41384543 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144617542 | chr19:41384569-41384570 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568938238 | chr19:41384577-41384578 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4453619 | chr19:41384578-41384579 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs147884612 | chr19:41384589-41384590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553233666 | chr19:41384630-41384631 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs4079367 | chr19:41384637-41384638 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs191003934 | chr19:41384644-41384645 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs372855525 | chr19:41384647-41384648 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs369173002 | chr19:41384648-41384649 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs575296850 | chr19:41384659-41384660 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21364760 | CNVD |
Invasive pancreatic ductal carcinoma | 18765526 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Genital abnormality | 22378287 | CNVD |
Hypospadia | 22378287 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Astrocytoma | 22246337 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:41382600-41384400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr19:41382600-41386200 | Weak transcription | Lung | lung |
3 | chr19:41383200-41387000 | Weak transcription | Liver | Liver |
4 | chr19:41384400-41384800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr19:41385600-41386000 | Weak transcription | Ovary | ovary |
6 | chr19:41386000-41386200 | Enhancers | Ovary | ovary |
7 | chr19:41386200-41386400 | Bivalent/Poised TSS | HUES64 Cell Line | embryonic stem cell |
8 | chr19:41386200-41386600 | Bivalent/Poised TSS | H1 Cell Line | embryonic stem cell |
9 | chr19:41386200-41386600 | Enhancers | Lung | lung |
10 | chr19:41386200-41386600 | Flanking Active TSS | Ovary | ovary |